Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multidrug resistance: a solvable problem?

P Borst1

  • 1The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|August 7, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Markedly increased risk of postoperative bleeding complications during perioperative bridging anticoagulation in general and visceral surgery.

Perioperative medicine (London, England)·2020
Same author

N-lactoyl-amino acids are ubiquitous metabolites that originate from CNDP2-mediated reverse proteolysis of lactate and amino acids.

Proceedings of the National Academy of Sciences of the United States of America·2015
Same author

ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release.

Proceedings of the National Academy of Sciences of the United States of America·2013
Same author

The organization of repeating units in mitochondrial DNA from yeast petite mutants.

Current genetics·2013
Same author

New physiological functions for drug-transporting P-glycoproteins?

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2006
Same author

From cancer cells to trypanosomes and back again.

Cellular and molecular life sciences : CMLS·2006
Same journal

The ethical obligation to use positive trial results.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

Lorlatinib: The Crown Jewel of ALK Inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

TROP2-Directed Antibody Drug Conjugates: New First-Line Treatment for All Patients with Advanced Triple-Negative Breast Cancer?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

When artificial intelligence learns to abstain: towards clinically responsible diagnostic support in liver pathology.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

Refining decision making in hormone receptor-positive early-stage breast cancer: moving from static to dynamic.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
See all related articles

Pancreatic cancer chemotherapy is disappointing due to primary drug resistance. This review examines drug pumps in other cancers as a potential mechanism for pancreatic cancer drug resistance, awaiting a breakthrough drug.

Area of Science:

  • Oncology
  • Cancer Biology
  • Pharmacology

Background:

  • Pancreatic cancer exhibits primary resistance to current chemotherapy drugs.
  • The mechanisms underlying this drug resistance in pancreatic tumors are not well understood.
  • Developing effective treatments is hindered by the lack of a highly potent chemotherapeutic agent.

Purpose of the Study:

  • To review existing knowledge on drug pump mechanisms in cancer cells.
  • To explore how these drug pumps contribute to chemotherapy resistance.
  • To provide insights into potential strategies for overcoming pancreatic cancer drug resistance.

Main Methods:

  • Literature review of studies on drug pumps and chemotherapy resistance.
  • Analysis of mechanisms by which cancer cells extrude drugs.

Related Experiment Videos

  • Synthesis of information on drug efflux pumps in various cancer types.

    • Main Results:

    • Drug pumps, such as P-glycoprotein, are a known mechanism for cancer cells to expel chemotherapy drugs.
    • These efflux pumps can render initially effective chemotherapy treatments ineffective.
    • Understanding these pumps is crucial for developing strategies to circumvent drug resistance.

    Conclusions:

    • Pancreatic cancer's resistance to chemotherapy may involve drug efflux pumps.
    • Further research into drug pump inhibitors could enhance chemotherapy efficacy.
    • Identifying effective drugs and overcoming resistance mechanisms are key to improving pancreatic cancer treatment outcomes.